Pharmacists in Pittsfield, IL Accepting Medicare

6 Pharmacists found. Showing 1 - 6

Erica Dawn Thomas, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 825 W Washington St, Pittsfield, IL 62363 Phone: 217-285-5515    Fax: 217-285-1326

Margaret Hanzel, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 640 W Washington St, Pittsfield, IL 62363 Phone: 217-285-2113    Fax: 217-285-1733

Dr. Caitlin M Holland, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 640 W Washington St, Pittsfield, IL 62363 Phone: 217-285-2113    Fax: 217-285-1733

Mr. Mark Anthony Tatum, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 640 W Washington St, Pittsfield, IL 62363 Phone: 217-285-2113    Fax: 217-285-1733

Mrs. Michelle Lynn Resiche Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 151 Shetland Dr, Pittsfield, IL 62363 Phone: 217-285-9709    Fax: 217-285-6761

Tracy Schutte Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 151 Shetland Dr, Pittsfield, IL 62363 Phone: 217-285-9709

News Archive

PQBP1 protein could improve body's immune response to HIV vaccines

In a scientific discovery that has significant implications for preventing HIV infections, researchers at Sanford-Burnham Medical Research Institute have identified a protein that could improve the body's immune response to HIV vaccines and prevent transmission of the virus.

First Edition: November 2, 2011

In today's headlines, reports about Tuesday's super committee hearing and the message communicated by bipartisan budget hawks to the panel - raise revenue and revamp health programs.

Study opens up array of options for developing treatments for cancer or autoimmune disorder

Immunologists at St. Jude Children's Research Hospital have discovered key biological switches that control regulatory T cells-specialized white blood cells that keep the immune system in check.

Phase 1 study of STX107 for Fragile X syndrome begins

NIH-supported scientists at Seaside Therapeutics in Cambridge, Mass., are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile X syndrome, the most common inherited cause of intellectual disability. There has to date been no medication that could alter the disorder's neurologic abnormalities. The study will evaluate safety, tolerability, and optimal dosage in healthy volunteers.

Read more Medical News

› Verified 1 days ago